在与乙型肝炎相关的补偿性肝硬化和补偿性肝硬化中,肝细胞癌的切除
Hang Zheng1, Qiqi Liu2,3, Nijin Wu4
1Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
European radiology
|November 14, 2025
概括
废除疗法是一种安全有效的治疗肝细胞癌 (HCC) 患者与乙型肝炎相关的补偿性肝硬化. 这项研究发现,与补偿性肝硬化患者相比,并发症或生存率没有显著差异.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 肝细胞癌 (HCC) 是一个主要的全球健康问题,特别是在慢性乙型肝炎感染的患者中.
- 肝硬化是慢性肝病的后果,显著影响HCC治疗结果.
- 区分补偿和补偿性肝硬化对于定制治疗策略至关重要.
研究的目的:
- 评估和比较乙型肝炎相关的补偿性肝硬化与补偿性肝硬化患者的HCC废除疗法的安全性和有效性.
- 为了确定废弃疗法在这两组患者中是否提供了可比的结果.
主要方法:
- 这是一项多中心的回顾性队列研究,涉及739名与乙型肝炎相关的HCC患者,这些患者接受了废除疗法.
- 患者被分为补偿性肝硬化 (n=73) 和补偿性肝硬化 (n=666) 组.
- 使用倾向性得分匹配,创建了73对匹配对,以进行无复发生存率 (RFS),总生存率 (OS) 和并发症率的可靠比较.
主要成果:
- 经过倾向性得分匹配后,在补偿和补偿肝硬化组之间没有观察到重大并发症的显著差异 (6.8%与2.7%,p=0.438).
- 在任何一组中都没有发生术后肝功能衰竭或脱补偿的情况.
- 这两组的无复发生存率和整体生存率在1,3年和5年之间是可比的,没有统计学上显著的差异 (RFS的p=0.699,OS的p=0.363).
结论:
- 废除疗法在治疗乙型肝炎相关的补偿性肝硬化患者中显示出良好的安全性和有效性.
- 它代表了补偿性肝硬化患者的可行的治愈治疗选择,类似于补偿性肝硬化患者.
- 这些发现支持在乙型肝炎相关的HCC患者中,不论肝硬化是否得到补偿或补偿,都应采用废除疗法.
相关概念视频
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...